Related Experiment Video
Updated: Apr 20, 2026

Fabrication of a Bioactive, PCL-based "Self-fitting" Shape Memory Polymer Scaffold
Published on: October 23, 2015
Injectable radiopaque and bioactive polycaprolactone-ceramic composites for orthopedic augmentation
Young Jung No1, Seyed-Iman Roohani-Esfahani1, Zufu Lu1
1Biomaterials and Tissue Engineering Research Unit, School of AMME, University of Sydney, 2006, Australia.
This study developed an injectable bone void filler using polycaprolactone (PCL) and baghdadite particles. The PCL-10%Bag composite showed promising mechanical properties and osteogenic potential for orthopedic applications.
Area of Science:
- Biomaterials Science
- Orthopedic Engineering
- Materials Science
Background:
- Bone void fillers are crucial in orthopedic and trauma surgery to repair bone defects.
- Current materials often lack ideal injectability, mechanical strength, or osteoconductivity.
- Developing novel injectable bone fillers with enhanced properties is an ongoing research area.
Purpose of the Study:
- To develop and characterize an injectable bone void filler composite material.
- To investigate the effects of incorporating baghdadite particles into polycaprolactone (PCL).
- To evaluate the injectability, mechanical properties, radiopacity, degradation, and cytocompatibility of the PCL-baghdadite composites.
Main Methods:
- Polycaprolactone (PCL) was composited with varying volume percentages of baghdadite particles (1-30%).
- Injectability, setting time, mechanical properties (compressive strength, modulus, flexural strength), radiopacity, degradation, and cytocompatibility were assessed.
- Primary human osteoblasts were cultured on the PCL-10%Bag composite to evaluate cellular response.
Main Results:
- Composites with up to 10% baghdadite (PCL-10%Bag) demonstrated excellent injectability at 75°C with low injection forces (<1.5 kN).
- Setting time was rapid (2.5-3.5 min) post-injection at 37°C.
- Baghdadite incorporation significantly enhanced compressive strength (up to 47.1 MPa) and modulus (up to 741 MPa) compared to pure PCL.
- PCL-10%Bag exhibited superior flexural strength (29.8 MPa) and significant upregulation of osteogenic genes in human osteoblasts.
Conclusions:
- The PCL-10%Bag composite shows excellent injectability, rapid setting, and improved mechanical properties.
- The material demonstrates good cytocompatibility and promotes osteogenic activity, making it suitable for bone regeneration.
- PCL-10%Bag is a promising candidate for injectable bone void filler applications in orthopedics and trauma surgery.
More Related Videos
08:41Calvarial Model of Bone Augmentation in Rabbit for Assessment of Bone Growth and Neovascularization in Bone Substitution Materials
Published on: August 13, 2019
06:38Establishment of a Segmental Femoral Critical-size Defect Model in Mice Stabilized by Plate Osteosynthesis
Published on: October 12, 2016